Publicaciones en las que colabora con María Jesús Monte Río (27)
2020
-
Role of genetic variations in the hepatic handling of drugs
International Journal of Molecular Sciences, Vol. 21, Núm. 8
2019
-
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib
British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800
2016
-
Protective role of biliverdin against bile acid-induced oxidative stress in liver cells
Free Radical Biology and Medicine, Vol. 97, pp. 466-477
2014
-
The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
Acta Pharmacologica Sinica, Vol. 35, Núm. 1, pp. 1-10
2011
-
A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis
Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 219-225
2007
-
Expression in Human Trophoblast and Choriocarcinoma Cell Lines, BeWo, Jeg-3 and JAr of Genes Involved in the Hepatobiliary-like Excretory Function of the Placenta
Placenta, Vol. 28, Núm. 2-3, pp. 107-117
-
Novel bile acid derivatives (BANBs) with cytostatic activity obtained by conjugation of their side chain with nitrogenated bases
Biochemical Pharmacology, Vol. 73, Núm. 9, pp. 1394-1404
2006
-
Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver
Life Sciences, Vol. 79, Núm. 10, pp. 1014-1019
-
Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy
Journal of Hepatology, Vol. 44, Núm. 6, pp. 1150-1157
2005
-
Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis
Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 2, pp. 751-758
2003
-
Physiological characteristics of allo-cholic acid
Journal of Lipid Research, Vol. 44, Núm. 1, pp. 84-92
2001
-
Estudio preclínico del Bamet-U2, un nuevo citostático no nefrotóxico derivado del cisplatino
Mapfre Medicina, Vol. 12, Núm. 1, pp. 33-38
-
Predominance of human versus rat phenotype in the metabolic pathways for bile acid synthesis by hybrid WIF-B9 cells
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1534, Núm. 1, pp. 45-55
2000
-
Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1500, Núm. 2, pp. 153-160
1999
-
Cholephilic characteristics of a new cytostatic complex of cisplatin with glycocholate (Bamet-R2)
Journal of Controlled Release, Vol. 57, Núm. 2, pp. 161-169
1998
-
Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta
Journal of Hepatology, Vol. 28, Núm. 5, pp. 829-839
-
DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2
International Journal of Cancer, Vol. 78, Núm. 3, pp. 346-352
-
In vitro test to determine the effect of cytostatic drugs on co-cultured rat hepatocytes and hepatoma cells
International Journal of Experimental Pathology, Vol. 79, Núm. 2, pp. 109-115
1997
-
Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat
Hepatology, Vol. 26, Núm. 3, pp. 527-536